Workflow
Securities Lawsuit
icon
Search documents
SOUN Shareholders Have the Right to Lead the SoundHound AI, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - SOUN
Prnewswire· 2025-05-27 05:30
Core Viewpoint - A class action lawsuit has been filed against SoundHound AI, Inc. for violations of federal securities laws, specifically related to misleading statements and weaknesses in financial reporting controls [1][2]. Group 1: Lawsuit Details - The lawsuit alleges that SoundHound made false and misleading statements to the market, particularly regarding its internal controls over financial reporting [2]. - The company is accused of overstating its remediation of internal control weaknesses and inflating reported goodwill following its acquisition of Amelia [2]. - Delays in accounting for acquisitions, including those of Amelia and SYNQ3, led to the company's failure to file certain financial reports with the SEC on time [2]. Group 2: Shareholder Information - Shareholders who purchased securities between May 10, 2024, and March 3, 2025, are encouraged to contact the law firm to participate in the class action [1][3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents large hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].
Lawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation
Prnewswire· 2025-05-13 14:35
Core Viewpoint - A lawsuit is pending against Pacira BioSciences, Inc. for alleged violations of securities laws related to misleading statements about patent protections for Exparel, which is critical for the company's revenue growth [2]. Group 1: Lawsuit Details - An investor filed a lawsuit on January 13, 2025, claiming that Pacira made false statements regarding the patent protections for Exparel, which accounts for approximately 80% of the company's revenue [2]. - The lawsuit alleges that Pacira misrepresented the strength of the '495 patent, which was invalidated in a separate case, leading to concerns that generic competition could arise during the patent's life [2]. Group 2: Investor Information - Shareholders who purchased shares of Pacira BioSciences, Inc. prior to August 2023 and continue to hold them are encouraged to contact the Shareholders Foundation for options regarding the lawsuit [1][3].
Lawsuit for Investors in shares of Manhattan Associates, Inc. (NASDAQ: MANH) announced by the Shareholders Foundation
Prnewswire· 2025-05-07 13:40
Core Viewpoint - A lawsuit is pending against Manhattan Associates, Inc. for alleged violations of securities laws, with claims that the company misled investors regarding its revenue outlook and growth potential [2]. Group 1: Lawsuit Details - The lawsuit was filed by an investor on February 25, 2025, alleging that Manhattan Associates made false and misleading statements about its financial health and growth prospects [2]. - The plaintiff claims that the company created a false impression of having reliable information about its projected revenue and growth while downplaying risks associated with seasonality and macroeconomic fluctuations [2]. - It is asserted that the company's optimistic reports on growth in its professional services did not align with the actual performance, particularly in light of macroeconomic challenges [2]. Group 2: Investor Information - Shareholders who purchased shares of Manhattan Associates prior to October 2024 and continue to hold them are encouraged to contact the Shareholders Foundation for options regarding the lawsuit [1][3]. - The Shareholders Foundation provides services related to shareholder issues, including information on securities class actions and legal news relevant to the financial market [3].
Lawsuit for Investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) announced by the Shareholders Foundation
Prnewswire· 2025-04-30 11:25
SAN DIEGO, April 30, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM).Investors who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) prior to October 2022 and continue to hold any of thoseNYSE: ATNM shares also have certain options and contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.On March 27, 2025, aNYSE: ATNM investor filed a lawsuit agai ...